Drugs / clostridium botulinum toxin type A neurotoxin complex
last change Oct 2010 re-read 3 minutes ago

clostridium botulinum toxin type A neurotoxin complex

Developed for
depressive disorder
Investigated by
Hannover Medical School · University Hospital, Basel, Switzerland

Trials 1

201020112012201320142015201620172018201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 2 NCT00934687 Aug 2009 → Oct 2010 depressive disorder University Hospital, Basel, Switzerland Completed No outcome recorded

Evidence & citations 2 cited values

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as clostridium botulinum toxin type A neurotoxin complex ClinicalTrials.gov intervention name — accepted as the source's own label NCT00934687 ↗
Route Other “will be injected at four to six sites in the glabella region” NCT00934687 ↗